Your browser doesn't support javascript.
loading
High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.
Stroot, Iris A S; Brouwer, Jan; Bart, Joost; Hollema, Harry; Stommel-Jenner, Denise J; Wagner, Marise M; van Doorn, Helena C; de Hullu, Joanne A; Gaarenstroom, Katja N; Beurden, Marc; van Lonkhuijzen, Luc R C W; Slangen, Brigitte F M; Zweemer, Ronald P; Gómez Garcia, Encarna B; Ausems, Margreet G E M; Boere, Ingrid A; van Engelen, Klaartje; van Asperen, Christi J; Schmidt, Marjanka K; Wevers, Marijke R; de Bock, Geertruida H; Mourits, Marian J E.
Afiliação
  • Stroot IAS; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Brouwer J; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Bart J; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Hollema H; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Stommel-Jenner DJ; Department of Pathology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Wagner MM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Doorn HC; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • de Hullu JA; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Gaarenstroom KN; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Beurden M; Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, the Netherlands.
  • van Lonkhuijzen LRCW; Department of Gynecology, Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
  • Slangen BFM; Department of Gynecologic Oncology, Amsterdam University Medical Center-Center for Gynecological Oncology Amsterdam, Amsterdam, the Netherlands.
  • Zweemer RP; Department of Gynecology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Gómez Garcia EB; Department of Gynecologic Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Ausems MGEM; Department of Clinical Genetics, University Medical Center Maastricht, Maastricht, the Netherlands.
  • Boere IA; Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
  • van Engelen K; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • van Asperen CJ; Department of Human Genetics, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Schmidt MK; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Wevers MR; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Bock GH; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  • Mourits MJE; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
J Clin Oncol ; 41(14): 2523-2535, 2023 05 10.
Article em En | MEDLINE | ID: mdl-36809028

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma / Neoplasias das Tubas Uterinas Tipo de estudo: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma / Neoplasias das Tubas Uterinas Tipo de estudo: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos